Is TYRA options pricing rich or cheap right now?

As of Aug 28, 2026, Tyra Biosciences, Inc. (TYRA) ATM IV is 223.6% against 20-day realized volatility of 91.2%. IV rank is 48.2%. TYRA options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 132.4 vol points.

What is the TYRA variance risk premium?

The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. TYRA is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.

What does TYRA IV rank mean for strategy selection?

IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. TYRA's current rank of 48.2% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.

Tyra Biosciences, Inc. (TYRA) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Tyra Biosciences, Inc. (TYRA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.49B, listed on NASDAQ, employing roughly 87 people, carrying a beta of 0.77 to the broader market. Tyra Biosciences, Inc. Led by Todd Harris, public since 2021-09-15.

Snapshot as of Aug 28, 2026.

Spot Price: $25.18
ATM IV: 223.6%
HV 20-Day: 91.2%
HV 60-Day: 65.8%
IV Rank: 48.2%
IV Percentile: 92.1%

As of Aug 28, 2026, Tyra Biosciences, Inc. (TYRA) ATM implied volatility is 223.6%. 20-day realized volatility is 91.2%, producing an IV-HV spread of +132.4 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 48.2%.

How TYRA iv/hv history Data Feeds Strategy Selection

Strategy selection on Tyra Biosciences, Inc. options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 223.6% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the TYRA IV vs HV chart

The dual-line chart above tracks ATM implied volatility (forward-looking, what the chain is pricing) against 20-day realized historical volatility (backward-looking, what actually happened). ATM IV currently prints at 223.6%, 48.2% IV rank, against 91.2% realized over the trailing 20 trading days. Implied is pricing above realized by 132.4 vol points, the typical variance-risk-premium positive state in which premium sellers earn the gap. Persistent IV-above-HV is the variance-risk-premium-positive state typical of equity markets; persistent IV-below-HV is rare and usually marks underpriced vol that often expands.

TYRA IV/HV regimes and trade selection

TYRA IV rank at 48.2% sits mid-range - no structural edge from rank alone. Strategy choice should follow event calendar and the dealer-positioning read.

Using TYRA vol history alongside the term structure

The IV/HV gap on this page captures the level of premium; the term-structure slope on the volatility page captures its shape across expirations. Backwardation (negative slope -0.430) indicates acute near-term event risk - near-dated tenors price disproportionate vol. Pair the rank read with the slope read with the event calendar to choose the right tenor for the structure.

TYRA IV/HV signal in volatility-cycle context

Equity-vol cycles tend to compress and expand on multi-month timeframes: a typical sequence runs low-IV-rank consolidation (months of flat tape, decaying premium) into a vol-expansion catalyst (earnings miss, macro shock, regime change) into elevated-IV-rank stress (premiums fat, dispersion high) back to mean-reverting compression. TYRA's 48.2% IV rank places the ticker in the mid-range of its 1-year window - no strong cycle-position signal. The ratio of HV-20 (91.2%) to HV-60 (65.8%) gives a second cycle indicator: when 20-day exceeds 60-day, recent realization is running hotter than the trailing-quarter average - typically a sign that recent days have already started expanding vol regardless of where IV rank prints. Use the time series above to spot inflection points: meaningful IV/HV gap closures and openings tend to precede regime shifts by a few sessions.

Learn how implied vs realized volatility is reported and how to read the data →

Daily ATM implied volatility and 20-day realized (historical) volatility for TYRA over the last ~42 trading days. The IV-HV gap measures the variance risk premium - when IV trades persistently above realized HV, premium-sellers earn the spread; when IV dips below HV, vol is structurally underpriced.

Daily values from end-of-day option_ticker_snapshots. Series sparse on illiquid tickers reflects gaps in the upstream end-of-day options data feed.

Most recent 15 trading days (descending). Older history appears in the chart above.

Date	ATM IV	HV 20d	HV 60d	IV Rank
Aug 28, 2026	223.6%	91.2%	65.8%	48.2%
Aug 27, 2026	211.2%	90.8%	65.3%	45.3%
Aug 26, 2026	227.4%	94.3%	66.1%	49.1%
Aug 25, 2026	207.3%	94.2%	68.3%	44.3%
Aug 24, 2026	194.2%	94.0%	68.2%	41.2%
Aug 21, 2026	165.5%	96.1%	68.2%	34.4%
Aug 20, 2026	141.1%	95.9%	68.1%	28.6%
Aug 19, 2026	142.3%	95.3%	68.2%	28.8%
Aug 18, 2026	147.4%	94.6%	68.0%	30.1%
Aug 17, 2026	159.3%	94.8%	68.1%	32.9%
Aug 14, 2026	140.5%	94.2%	67.8%	28.4%
Aug 13, 2026	140.9%	95.1%	68.0%	28.5%
Aug 12, 2026	133.4%	95.1%	68.4%	26.7%
Aug 11, 2026	345.2%	95.2%	68.5%	77.2%
Aug 10, 2026	441.1%	94.9%	68.2%	100.0%

Frequently asked TYRA iv/hv history questions

Is TYRA options pricing rich or cheap right now?: As of Aug 28, 2026, Tyra Biosciences, Inc. (TYRA) ATM IV is 223.6% against 20-day realized volatility of 91.2%. IV rank is 48.2%. TYRA options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 132.4 vol points.
What is the TYRA variance risk premium?: The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. TYRA is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
What does TYRA IV rank mean for strategy selection?: IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. TYRA's current rank of 48.2% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.